The next step for Congress: Cutting a separate deal on twelve individual pockets of money—before any bill can be written, with a shutdown looming. Congressional appropriators are sprinting to turn two big funding totals into 12, after party leaders secured a deal on a government funding framework over the weekend. For weeks, House Speaker Mike Johnson and Senate Majority Leader Chuck Schumer’s staff have haggled over budget totals for the military and domestic programs—only to wind up with the same funding limits set by last summer’s bipartisan debt agreement.

Pressure injuries, falls, central line–associated bloodstream infections, catheter-associated urinary tract infections, and other hospital-acquired conditions (HACs) develop while a patient is in the hospital being treated for another condition. They not only cause patient harm, but they also contribute to escalating costs of care. For example, in the United States, the annual cost of treating pressure injuries is estimated as high as $22 billion, with expenses for a single pressure injury ranging from $500–$70,000. 

When mapping out our career journey, many oncology nurses have found ourselves asking: Should I go back to school and get my master’s degree? How do I juggle it all? I am raising a family and trying to work full-time, but I would also love to grow in my nursing career. How can I be successful at it all?

The Senate Health Committee advanced legislation Thursday that would fund community health centers and increase the number of primary care physicians and nurses, despite a clash between the panel’s top members. The Health, Education, Labor, and Pensions Committee advanced the bill in a bipartisan 14-7 vote; however, it’s unclear if the bill has the support necessary to pass the full Senate, especially before funding expires September 30.

Both collaborative and authoritative communication approaches have value in educating and engaging patients. When deciding which style to use with each patient, oncology nurses must evaluate the individual, situation, and decision-making dynamics. 

When summer ends in the northern hemisphere and the autumnal equinox ushers in fall on September 23, 2023, the earth begins to tilt away from the sun, making the nights grow longer and days shorter until the winter solstice. Those of us working 12-hour shifts especially notice the decrease in daylight, coming to and leaving our workplaces in darkness. 

Join ONS member Ashley Barill, BSN, OCN®, nurse supervisor at WVU Medicine in Morgantown, WV, as she explains how she and her team train using mock code simulations in an outpatient infusion center in this video. Mock code simulations can help oncology nurses and other healthcare professionals prepare for emergencies, and Barill’s tips and resources are helpful tools when conducting those simulations. 

ONS donated a library of oncology nursing publications to healthcare providers from Ethiopia who traveled to City of Hope in Duarte, CA, in February 2023 for a three-week radiation training program.

Nurses often cite the fact that the profession is the most trusted, according to Gallup polls—as if that is enough to validate our profession’s status. Although the COVID-19 pandemic raised awareness for frontline workers, only recently have we begun to understand the nurse’s value in the health policy environment. Nurses have a real voice at the decision-making table, and Healing Politics’ Campaign School for Nurses and Midwives is helping to make strides.

Recognizing the critical need to expand advanced practices RNs’ education and training and geographically diverse work opportunities, especially in rural and underserved communities, Representatives Lauren Underwood (D-IL), Suzanne Bonamici (D-OR), and Steven Horsford (D-NV) introduced the Educating Future Nurses Act in the U.S. House of Representatives in May 2023. At the same time, Senators Debbie Stabenow (D-MI), Bob Casey (D-PA), and Maggie Hassan (D-NH) introduced the legislation in the U.S. Senate.

First responders’ persistent exposures to toxic chemicals, abnormal sleep schedules, and constant stress may lead to a higher risk of developing cancer. In particular, firefighters have a 9% higher risk for a cancer diagnosis and a 14% higher risk of cancer mortality compared to the general population.

Join ONS member Suzanne Mahon, RN, AOCN®, AGN-BC, FAAN, professor at Saint Louis University in Missouri and member of the St. Louis ONS Chapter, as she demonstrates how to examine and explore germline genomic testing reports. Understanding these reports is critical when providing patient education, and Mahon’s tips and tricks when identifying report components and their importance are helpful tools for oncology nurses to consider in their practice.

A combination of intensive chemotherapy immunotherapy administration education and shorter training on oncology symptom management can prepare correctional facility nurses to safely care for patients with cancer in the community, according to presenters in an oral abstract session at the 48th Annual ONS Congress^® in April 2023.

Fumarate hydratase deficiency occurs in individuals who have homozygous pathogenic variants in the tumor suppressor FH gene. The condition results in poor feeding, failure to thrive, hypotonia, lethargy, and seizures. Development is severely delayed, and individuals are often nonverbal, unable to walk, and die in early childhood.

Listening to educational podcasts improves oncology nurse learners’ knowledge of managing treatment-related adverse events by 11%–27% and safety by 24%, researchers reported during a podium presentation at the 48th Annual ONS Congress® in April 2023.

Macy is a 57-year-old patient with a history of hormone receptor–positive invasive ductal carcinoma of the right breast, diagnosed in 2017. She achieved complete remission after chemotherapy with anthracycline plus paclitaxel followed by bilateral mastectomy with reconstruction in 2018.

A multimodal nursing education intervention using ONS resources, didactic teaching, and small group discussions grew one institution’s advance care planning (ACP) documentation rates from 0% to 63%, according to a report published in the February 2023 issue of the Clinical Journal of Oncology Nursing. Nurse participants also reported increases in ACP discussions and a clinically significant improvement in their overall comfort level with ACP conversations.

Meaningful communication involves more than just words traded between people. By asking open-ended questions, affirming a person’s strengths, offering reflections, and providing a summary of the conversation, you can engage others in meaningful conversation.

In February 2023, the Tandem Transplantation and Cellular Therapy Meetings of ASTCT and CIBMTR brought the latest cutting-edge science and technologies in hematopoietic cell transplantation and cellular therapy to nurses around the globe. Here are some of the highlights I experienced as an advanced practice provider (APP) in blood and marrow stem cell transplantation.

Schoolhouse Rock! celebrated its 50th anniversary in January 2023. The Saturday morning cartoons debuted in 1973 and brought school lessons on a variety of subjects, including government and democracy, to children through catchy yet educational lyrics and beats. 

Individuals who identify as transgender and non-binary may no longer use their birth or legal name but rather choose a new name that aligns with their identity. When they ask that you use their new name instead, calling them by their old name is referred to as deadnaming and can be a stressful and traumatic experience for the individual and is even considered an act of verbal violence.

Nearly 60% of RNs say they have limited awareness of the concept of reasonable accommodations for patients with intellectual disabilities, researchers reported in the Journal of Advanced Nursing. They said their findings indicate a dire need for increased nursing education and training.

Disparity. Inequity. Futility. Barriers. Miscommunication. Unacceptance of the inevitable. Ethical and moral challenges perpetuate throughout practice for today’s healthcare workers, particularly oncology nurses in cancer care. As those burdens build up, nurses struggle to sustain their resilience and risk developing burnout or even leaving the profession entirely.

Many patients with cancer confront complex health disparities, but those with disabilities must muddle through more barriers than those without. As nurses, we have a responsibility to help our patients obtain the best possible care and support them during treatments such as a bone marrow transplantation. 

Weight bias and stigma are evident across all professionals in the health care industry, including physicians, nurses, dietitians, and mental healthcare providers, researchers reported in Nursing Clinics of North America. They said that using people-first language is critical to reducing bias and discrimination.

More than two dozen people were charged for alleged participation in a wire fraud scheme that created an illegal licensing and employment shortcut for nursing candidates following an investigation launched by the U.S. Department of Health and Human Services Office of Inspector General and law enforcement in January 2023.

According to the World Health Organization, cancer is the leading cause of death worldwide, accounting for nearly 10 million deaths each year. That alarming statistic reminds us that we are part of a global network of oncology nurses caring for those diagnosed with cancer. For many people in low- to middle-income countries, late-stage disease, premature death, and pain and suffering are common. Opioids and supportive care medications are sometimes sparse, and clinicians lack the knowledge and resources to provide palliative care.

Maintaining a patient’s personal grooming during an inpatient stay is an important aspect of holistic nursing care, but nurses and hospitals alike may fall short when it comes to textured hair care, nurses reported in the American Journal of Nursing.

Direct-to-consumer genomic testing is a patient-initiated type of testing that is marketed to the general public in advertisements on all media. The tests can be purchased online or in stores without requiring a healthcare professional order or third-party payer authorization. Customers send a saliva sample to the company and view their test results on a secure website, but the results are not included in their electronic health record unless they specifically request it.

In the years following their initial licensure, nurses will often pursue certification. Obtaining certification shows a nurse’s commitment to their profession, specialty, and patients. Along with showing their commitment, certifications validate a nurse’s qualification and knowledge of a specific area.

Your nursing career might take many paths, but they all share a primary entry into professional practice: licensure. Licensure verifies that an RN understands and adheres to the laws and statutes that govern their profession as outlined in their state’s nurse practice act. In addition to defining your full scope of practice, your RN license also enables you to fully use your voice and advocate for your patients, as well as report medical errors in practice—both essential responsibilities when providing high-quality cancer care.

Essential biomarker testing technologies like next-generation sequencing are increasing our comprehension of cancer genetics and genomics. Biomarker testing results provide prognostic and predictive information about a tumor’s biology and growth to guide treatment decisions. Patients with cancer are turning to their oncology nurses to help them understand their complex test results and corresponding recommended treatment plans, yet many oncology nurses have minimal, if any, formal training in the area.

Making a commitment to equip today’s and future nurses with the knowledge they need to deliver safe, high-quality care, the U.S. Department of Health and Human Services, through the Health Resources and Services Administration, awarded $13 million in October 2022 to programs to improve access to. The awarded funds are part of a series of investments the Biden-Harris Administration earmarked to support pathways to nursing jobs.

The White House Office of Science and Technology Policy updated policy guidance in August 2022 to allow the average American easier access to publications. The new guidance applies to taxpayer-funded research studies and makes the results publicly available for free.

An altered HOXB13 gene may increase a patient’s risk for developing prostate cancer. The HOXB13 gene is expressed in the prostate beginning in early development and affects prostate cell proliferation and differentiation and androgen receptor regulation. When it acts as a tumor suppressor gene, HOXB13 codes for a protein that regulates cell division. However, altered copies of HOXB13 are inactivated, meaning that it does not function properly or does not produce the protein it codes for, resulting in uncontrolled cell division.

Growing evidence suggests that the gut microbiome, a diverse and complex mix of microorganisms and their metabolites, is closely linked to the immune system, and researchers are studying whether modulating the gut microbiome affects cancer immunotherapy treatment outcomes. In particular, probiotics—which are flora typically obtained through dietary sources such as yogurt and fermented foods or via supplemental forms—are gaining prominence as a potential strategy to modulate the gut microbiome during cancer treatment.

In June 2021, I was at a crossroads in my career. I had been an oncology nurse practitioner for the past 14 years, and it was time to decide if I should retire as a provider. Yet I felt like I still had more to do and more patients to help. I was determined to make a difference for patients with cancer.

Before poly (adenosine diphosphate-ribose) polymerase (PARP) inhibitors were approved for ovarian cancer, traditional treatment consisted of surgical cytoreduction and platinum-based chemotherapy with a taxane, with or without bevacizumab, depending on stage and type. With the surgery-chemotherapy combination, 70%–75% of patients had recurrence and overall five-year survival rates were 29%, indicating a need for additional therapies.

My passion for biomarkers lies in research, specifically clinical trials. The incorporation of biomarkers in oncology clinical trials has been an important advancement in research, and we’ve seen the effect on improving patient outcomes. Identification of pathogenic variants is essential to prescribing personalized therapy for patients with cancer.

Sexual dysfunction is one of the most common side effects of cancer treatment, yet oncology professionals often under address patients’ sexuality and sexual dysfunction concerns. Providers cite lack of time, training, and resources as barriers to initiating important discussions about sexual side effects, and studies show that patients’ age and prognosis are additional hindering factors.

Nurses’ consistent and correct use of genomics terminology is critical to reduce confusion and provide safe genomics care to patients and their families, especially when explaining the meaning of genomic tests or findings.

Cancer and its treatments can affect a patient’s body in many ways, including sexual function. However, the historical evidence base is focused on cisgender men and their sexual health post-cancer treatment, with sexual health of women and LGBTQIA+ patients largely ignored. I, and many others, are working to change these disparities in research and practice.

Human epidermal growth factor receptor 2 (HER2) proteins are involved in normal cellular growth and are found on the surface of all breast cells. Approximately 20% of breast cancers are HER2 positive, meaning they have high levels of HER2 protein, and those cancers typically grow and metastasize more quickly than other types of breast cancer.

Bringing the first agent to market for the indication, on August 5, 2022, the U.S. Food and Drug Administration (FDA) approved fam-trastuzumab deruxtecan-nxki (Enhertu®) for patients with unresectable or metastatic HER2-low breast cancer based on results from the DESTINY-Breast04 trial that demonstrated improved progression-free and overall survival. FDA also gave fam-trastuzumab deruxtecan its fourth approval on August 11, 2022, for unresectable or metastatic HER2-activating non-small cell lung cancer (NSCLC).

The National Institute of Nursing Research, an National Institutes of Health agency, released its 2022–2026 strategic plan in summer 2022 to support its mission of leading “nursing research to solve pressing health challenges and inform practice and policy—optimizing health and advancing health equity into the future.”

Medication administration is a high-risk process that requires critical thinking, efficient decision-making, attention to detail, and a foundational knowledge of basic pharmacology. The process is not a single task but a cascade of events that include handling, ordering, preparing, dispensing, administering, and monitoring. Although nurses’ involvement varies at each phase, the risk for errors always exists, and consequences can have a lifelong impact on patients, families, and healthcare workers. Nurses can use the following strategies in their responsibility as the last line of defense for safe medication administration.

The National Institutes of Health launched the Climate Change and Health Initiative to expand knowledge and address key challenges regarding the environment’s impact on health and conditions like cancer in a collaborating all-hands-on-deck scientific effort, Richard Woychik, PhD, director of the NIH’s National Institute of Environmental Health Sciences, said in a blog post in July 2022.

After clinical trials demonstrated a 25% response rate in patients with multiple myeloma, selinexor (Xpovio^®) received initial, accelerated U.S. Food and Drug Administration approval in 2019.

Recognizing past actions, seeking forgiveness, and outlining its approach for the future, the American Nurses Association unanimously adopted a racial reckoning statement in June 2022. According to the association, the statement was the first step in acknowledging previous actions that have marginalized nurses of color and perpetuated systemic racism.

On September 20, 2022, the U.S. Food and Drug Administration (FDA) approved the use of sodium thiosulfate (Pedmark®) to reduce the risk of ototoxicity associated with cisplatin in pediatric patients aged 1 month and older with localized, nonmetastatic solid tumors.